Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal misoprostol versus intravenous tranexamic acid during abdominal myomectomy
PACTR202607873538129Phase 0Not yet recruiting
- Sponsor
- Dr. John Oluwadamilola OJO
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial in Fibromyoma (LM) comparing Rectal misoprostol with Intravenous tranexamic acid (2 arms). Primary endpoint: Intraoperative estimated blood loss. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
misoprostoltranexamic acid
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202607873538129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607873538129.